Shri Ahimsa Naturals Ltd
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]
- Market Cap ₹ 626 Cr.
- Current Price ₹ 267
- High / Low ₹ 283 / 142
- Stock P/E 23.1
- Book Value ₹ 72.5
- Dividend Yield 0.00 %
- ROCE 24.4 %
- ROE 18.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 79.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.2%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 62.9 to 96.2 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Other Food Products
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 22 | 28 | 58 | 104 | 78 | 96 | 116 | |
| 18 | 24 | 41 | 54 | 51 | 65 | 81 | |
| Operating Profit | 4 | 4 | 17 | 50 | 27 | 31 | 35 |
| OPM % | 17% | 15% | 30% | 48% | 34% | 32% | 30% |
| 1 | 0 | 1 | 2 | 1 | 2 | 4 | |
| Interest | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 2 | 2 | 16 | 51 | 25 | 30 | 37 |
| Tax % | 27% | 32% | 30% | 29% | 26% | 26% | |
| 1 | 2 | 11 | 36 | 19 | 22 | 27 | |
| EPS in Rs | 3.44 | 3.37 | 21.53 | 68.21 | 10.21 | 9.42 | 11.61 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 18% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 79% |
| 3 Years: | 25% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 58% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 32% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 5 | 5 | 18 | 23 | 23 |
| Reserves | 6 | 9 | 22 | 58 | 66 | 131 | 146 |
| 14 | 13 | 6 | 3 | 14 | 0 | 0 | |
| 4 | 4 | 7 | 8 | 5 | 38 | 10 | |
| Total Liabilities | 27 | 31 | 41 | 74 | 103 | 193 | 180 |
| 15 | 17 | 21 | 28 | 32 | 39 | 39 | |
| CWIP | 0 | 1 | 3 | 3 | 6 | 2 | 0 |
| Investments | 0 | 0 | 0 | 1 | 10 | 10 | 20 |
| 12 | 12 | 17 | 42 | 55 | 143 | 121 | |
| Total Assets | 27 | 31 | 41 | 74 | 103 | 193 | 180 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 6 | 3 | 14 | 20 | 6 | 43 | |
| -1 | -4 | -6 | -10 | -19 | -3 | |
| -5 | 1 | -6 | -4 | 10 | 34 | |
| Net Cash Flow | 0 | -0 | 3 | 7 | -4 | 74 |
| Free Cash Flow | 5 | -1 | 9 | 10 | -2 | 39 |
| CFO/OP | 162% | 84% | 91% | 68% | 46% | 161% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 53 | 62 | 25 | 39 | 53 | 96 |
| Inventory Days | 201 | 61 | 77 | 122 | 340 | 214 |
| Days Payable | 45 | 33 | 15 | 8 | 18 | 3 |
| Cash Conversion Cycle | 209 | 90 | 87 | 154 | 375 | 307 |
| Working Capital Days | -30 | -3 | 26 | 74 | 133 | 92 |
| ROCE % | 14% | 58% | 102% | 32% | 24% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Export Share of Total Revenue % |
|
|||
| Gross Current Assets (GCA) Days Days |
||||
| Installed Capacity - Caffeine Anhydrous Natural MTPA |
||||
| Installed Capacity - Green Coffee Bean Extract MTPA |
||||
| Inventory Holding Period Days |
||||
| Number of Countries with Sales Presence Count |
||||
| Number of Permanent Employees Count |
||||
Extracted by Screener AI
Documents
Announcements
-
Reply to Clarification- Financial results
13 April 2026 - Company clarified NSE queries on financial results format and submitted audited half-yearly and annual results for FY25.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 April 2026 - Regulation 74(5) certificate filed for quarter ended March 31, 2026.
-
Analysts/Institutional Investor Meet/Con. Call Updates
26 March 2026 - Virtual analyst/institutional investor meeting scheduled March 31, 2026, 2:00–3:00 PM; no unpublished information shared.
-
Trading Window
26 March 2026 - Trading window closed Apr 1, 2026 until 48 hours after audited FY2025-26 results.
-
Monitoring Agency Report
13 February 2026 - CARE report: IPO Rs50.02cr; Rs25cr invested; Rs21.16cr utilized; Rs13.84cr unutilised (Dec 31, 2025).
Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.